title: How best to manage treatment-resistant depression?
abstract: Should you augment the treatment regimen with lithium, thyroxin, or an atypical antipsychotic? This review will help you decide.
authors.affiliation: Department of Family and Community Medicine, University of Arizona, Tucson, AZ 85719, USA. Phicks@uph.org
authors.forename: Paul
authors.initials: P
authors.lastname: Hicks
authors.forename: Ximena Prieto
authors.initials: XP
authors.lastname: Hicks
authors.forename: Heidi
authors.initials: H
authors.lastname: Meyer
authors.forename: Catherine
authors.initials: C
authors.lastname: Shisslak
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003863:Depression / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D005081:Exercise Therapy; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D017211:Treatment Failure; D014803:Vitamin B Complex / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D014803:Vitamin B Complex; D005492:Folic Acid; D008094:Lithium